treatment

Based on research, financial data and stakeholder surveys and testimonies, the UK government’s official drug policy advisers warn that without significant efforts to protect investment and quality, in England “loss of funding will result in...

Abstract Background A recent Cochrane review of randomised trials identified a lack of evidence for interventions provided to drug-using offenders. We use routine data to address whether contact with treatment services reduces heroin users’...

Key studies on the role of management and supervision in the treatment of problem drug use. Commentary asks, “Is there anything more instructive than *being* the patient?”, explores the role of patient choice and preferences in treatment...

One of our selection of hot topics on important issues which sometimes generate heated debate. Both as a treatment resource for the patient and a group needing support in their own right, families affected by substance use are, claimed a UK...

Seizing on the theory’s propaganda value, in 1997 the head of the US National Institute on Drug Abuse proclaimed, “Addiction Is a Brain Disease, and It Matters.” His contention has been hailed as a breakthrough or condemned as a...

In 2013 nalmefene was authorised for moderating drinking among patients not in need of detoxification, extending pharmacotherapy to less dependent drinkers. Though uniquely authorised for this purpose, this review found other (and probably...